Skip to main content

Main menu

  • Home
  • About
    • Clinical Chemistry
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
    • CE Credits
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Resources
    • AACC Learning Lab
    • Clinical Chemistry Trainee Council
    • Clinical Case Studies
    • Clinical Chemistry Guide to Scientific Writing
    • Clinical Chemistry Guide to Manuscript Review
    • Journal Club
    • Podcasts
    • Q&A
    • Translated Content
  • Abstracts
  • Submit
  • Contact
  • Other Publications
    • The Journal of Applied Laboratory Medicine

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
Clinical Chemistry
  • Other Publications
    • The Journal of Applied Laboratory Medicine
  • Subscribe
  • My alerts
  • Log in
Clinical Chemistry

Advanced Search

  • Home
  • About
    • Clinical Chemistry
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
    • CE Credits
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Resources
    • AACC Learning Lab
    • Clinical Chemistry Trainee Council
    • Clinical Case Studies
    • Clinical Chemistry Guide to Scientific Writing
    • Clinical Chemistry Guide to Manuscript Review
    • Journal Club
    • Podcasts
    • Q&A
    • Translated Content
  • Abstracts
  • Submit
  • Contact
Article CommentaryClinical Case Study

Commentary

Marilyn A. Huestis
DOI: 10.1373/clinchem.2014.224543 Published November 2014
Marilyn A. Huestis
National Institute on Drug Abuse, Baltimore, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mhuestis@intra.nida.nih.gov
  • Article
  • Info & Metrics
  • PDF
Loading

Drug testing is an important component of pain management, and a growing laboratory industry. Simultaneous increases in the abuse of opioid medications and the numbers of patients seeking pain relief have necessitated drug monitoring in patients receiving pain medications. An additional factor contributing to the development of drug monitoring programs has been the increasing rate of opioid-related deaths involving prescribed opioids rather than heroin overdoses. Drug monitoring programs seek to demonstrate that patients are in compliance with currently prescribed medications, that they exhibit no evidence of using nonprescribed medications including illicit drugs, and that there is no evidence of diversion of scheduled opioids. Individuals in pain management treatment have been shown to have a higher rate of substance abuse than the general population, and some individuals receive multiple prescriptions from multiple physicians, sometimes selling these opioids to substance abusers.

This case study demonstrates the complexities of pain-management drug testing and the limitations of immunoassays to provide the needed information for proper interpretation of urine drug test results. As shown in this case, in-house urine immunoassays for 6-acetylmorphine and buprenorphine tested positive, and fentanyl results were invalid. These results caused the physician to consider illicit heroin abuse and use of the nonprescribed buprenorphine scheduled opioid, while providing no information on potential fentanyl use. All these misleading test results were caused by cross-reactivity of prescribed drugs or interference from a highly concentrated urine specimen. For these reasons, a chromatographic mass spectrometry confirmation test is almost always needed. In this case, the high urine morphine concentrations from prescribed morphine most likely triggered false-positive buprenorphine and 6-acetylmorphine immunoassay results, with a possible contribution of the patient's hydroxychloroquine medication, which also has been shown to generate false-positive buprenorphine results. The high urine creatinine concentration in this patient's urine also affected the ability of the fentanyl assay to yield valid immunoassay results. The case study documents the importance of laboratory professionals' knowledge and experience in informing the physician's interpretation of pain management urine test results.

Footnotes

  • Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; and (c) final approval of the published article.

  • Authors' Disclosures or Potential Conflicts of Interest: No authors declared any potential conflicts of interest.

  • Received for publication June 3, 2014.
  • Accepted for publication June 5, 2014.
  • © 2014 American Association for Clinical Chemistry
View Abstract
PreviousNext
Back to top

In this issue

Clinical Chemistry: 60 (12)
Vol. 60, Issue 12
December 2014
  • Table of Contents
  • About the Cover
  • Index by author
  • Table of Contents (PDF)
  • Cover (PDF)
  • Advertising (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
  • Audio summary of this issue
Print
Share
Commentary
Marilyn A. Huestis
Clinical Chemistry Dec 2014, 60 (12) 1484-1485; DOI: 10.1373/clinchem.2014.224543
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Commentary
Marilyn A. Huestis
Clinical Chemistry Dec 2014, 60 (12) 1484-1485; DOI: 10.1373/clinchem.2014.224543

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Clinical Case Study

  • Commentary
  • Persistent Jaundice and Multiple Fractures in a Newborn
  • Commentary
Show more Clinical Case Study

Commentaries

  • Commentary
  • Commentary
  • Commentary
Show more Commentaries

Similar Articles

Subjects

  • SUBJECT AREAS
    • Drug Monitoring and Toxicology

Options

  • Home
  • About
  • Articles
  • Information for Authors
  • Resources
  • Abstracts
  • Submit
  • Contact
  • RSS

Other Publications

  • The Journal of Applied Laboratory Medicine
Footer logo

© 2019 American Association for Clinical Chemistry

Powered by HighWire